The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial (Lancet Rheumatology, 2022)

(untitled) - Strand, V; Kaeley, GS; Bergman, MJ; Gladman, DD; Coates, LC; Sherif, B; Hur, P; Parikh, B; Gilloteau, I; Mease, PJ